Insider · CIK 0001388803
Jonathan S Sacks
Files at MDRX (Veradigm Inc.). First filing -, latest -.
In brief
Jonathan S Sacks files SEC Form 4 as director and 10% owner at MDRX (Veradigm Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan S Sacks has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MDRX Veradigm Inc. | AGrant or award Common Stock, par value $0.01 per share | +42,507 | $0.00 | $0 | 97,715 | Jun 3, 2026 |
| May 31, 2025 | MDRX Veradigm Inc. | MOption exercise Common Stock, par value $0.01 per share | +8,696 | - | - | 8,696 | Jun 3, 2025 |
| Jun 1, 2025 | MDRX Veradigm Inc. | AGrant or award Common Stock, par value $0.01 per share | +46,512 | $0.00 | $0 | 55,208 | Jun 3, 2025 |
| May 31, 2025 | MDRX Veradigm Inc. | MOption exercise Restricted Stock Unitsderivative | -8,696 | $0.00 | $0 | 0 | Jun 3, 2025 |
Questions about Jonathan S Sacks
Answered from the filings on this page, as of the latest one.
Is Jonathan S Sacks buying or selling?
Jonathan S Sacks has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan S Sacks's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan S Sacks has 0.
Where does Jonathan S Sacks file Form 4?
Jonathan S Sacks has filed Form 4 at MDRX (Veradigm Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.